IP Library Granted Patent US 8,957,210
Granted Patent B2
US 8,957,210 · App. 14/364,040 · Granted Feb 17, 2015

Method for synthesizing 1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridine-3-formamidine hydrochloride

Inventors: Jin Li (Jiangsu, CN); Xiaoyu Yang (Jiangsu, CN); Jingwei Zhu (Jiangsu, CN); Minmin Yang (Jiangsu, CN); Xihan Wu (Jiangsu, CN)
Assignee: Pharmablock (Nanjing) R&D Co., Ltd.
C07D471/04
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,957,210
App. No.
14/364,040
Granted
Feb 17, 2015
Kind
B2
Abstract

The present invention relates to the field of chemical synthesis, and in particular to a method for synthesizing 1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-formamidine hydrochloride, which is an important intermediate of Riociguat that is an anti-thromboembolic-disease medicine. The method is characterized in that: 3-iodo-1H-pyrazolo[3,4-b]pyridine is used as a raw material; the raw material is reacted with fluorobenzyl bromide to form a compound (10); the compound (10) is reacted with zinc cyanide to form a compound (6); the compound (6) is reacted with sodium methoxide, ammonium chloride, acetic acid and methanol to form a compound (8); and the compound (8) is reacted with chlorine hydride gas to form 1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-formamidine hydrochloride. The method has the characteristics of cheap and readily available raw materials, high yield, mild reaction conditions and the like, and is a synthesis method having a large-scale preparation value.

Claims (11)

1. A method for preparing compound (11), comprising:

wherein: the reaction condition in step VII: adding potassium carbonate;

the reaction condition in step VIII: adding zinc powder, zinc cyanide, 1,1′-bis(diphenylphosphine) ferrocene and tetra(triphenylphosphine)palladium;

the reaction condition in step V: adding methanol and sodium methoxide;

the reaction condition in step VI: adding ammonium chloride and acetic acid;

the reaction condition in step IX: adding hydrochloric acid or inputting hydrogen chloride.

2. The preparation method according to claim 1 , wherein the molar ratio of compound (9): o-fluorobenzyl bromide:potassium carbonate is 1:1˜1.5:1.5˜3.0.

3. The preparation method according to claim 1 , wherein in step VII, the reaction solvent is tetrahydrofuran, N,N-dimethylformamide or dimethylsulfoxide.

4. The preparation method according to claim 1 , wherein in step VIII, the reaction temperature is 100˜150° C. and the reaction solvent is N,N-dimethylacetamide.

5. The preparation method according to claim 1 , wherein in step VIII, the molar ratio of compound (10) and zinc cyanide is 1:0.7˜1:1.2.

6. The preparation method according to claim 1 , wherein in step IX, the reaction solvent is methyl tertiary butyl ether.

Assignments (2)
CHANGE OF NAME Recorded Dec 9, 2016
From: PHARMABLOCK (NANJING) R&D CO., LTD.
To: PHARMABLOCK SCIENCES (NANJING), INC.
Reel/Frame 040698/0611 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 13, 2014
From: ZHU, JINGWEI; YANG, XIAOYU; WU, XIHAN; YANG, MINMIN; LI, JIN
To: PHARMABLOCK (NANJING) R&D CO., LTD.
Reel/Frame 033096/0541 →
Priority Claims (1)
CN 2011 1 0414004 · Dec 12, 2011 · national
Continuity (1)
Related Publication 20140309425A1 · Oct 16, 2014